Literature DB >> 1902447

Macrophage-T cell interaction is essential for the induction of p75 interleukin 2 (IL-2) receptor and IL-2 responsiveness in human CD4+ T cells.

Y Nakamura1, T Nishimura, Y Tokuda, N Kobayashi, K Watanabe, T Noto, T Mitomi, K Sugamura, S Habu.   

Abstract

Fresh human CD8+ T cells showed a strong proliferative response to a high concentration of interleukin 2 (IL-2) in the absence of macrophages. In contrast, CD4+ T cells revealed no significant IL-2 responsiveness in the absence of macrophages. However, if CD4+ T cells were cocultured with macrophages, they showed higher proliferative response to IL-2 than CD8+ T cells. In accordance with the magnitude of IL-2 responsiveness, freshly isolated CD8+ T cells expressed significant amounts of p75 IL-2 receptor, while fresh CD4+ T cells did not express p75 IL-2 receptor. The expression of p75 IL-2 receptor on CD4+ T cells was induced by coculture with macrophages. The macrophage-induced p75 IL-2 receptor acquisition was blocked by monoclonal antibody (mAb) against class II antigen. Moreover, the addition of anti-CD4 mAb or anti-class II mAb to the culture caused a great inhibition of IL-2 responsiveness of CD4+ T cells. These results strongly suggest that macrophage-T cell interaction through CD4 and/or class II molecules is essential for the expression of p75 IL-2 receptor and IL-2 responsiveness in human CD4+, but not CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902447      PMCID: PMC5918393          DOI: 10.1111/j.1349-7006.1991.tb01839.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


interleukin 2 monoclonal antibody peripheral blood mononuclear cells
  17 in total

1.  Activation of peripheral blood T cells via the p75 interleukin 2 receptor.

Authors:  H Yagita; M Nakata; A Azuma; T Nitta; T Takeshita; K Sugamura; K Okumura
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

2.  IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.

Authors:  M H Ben Aribia; N Moiré; D Métivier; C Vaquero; O Lantz; D Olive; B Charpentier; A Senik
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

3.  rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2.

Authors:  M H Ben Aribia; E Leroy; O Lantz; D Métivier; B Autran; B Charpentier; T Hercend; A Senik
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

4.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.

Authors:  L T Bich-Thuy; M Dukovich; N J Peffer; A S Fauci; J H Kehrl; W C Greene
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

6.  A new high-yield continuous cell-culture system for lymphokine-activated killer cells.

Authors:  T Noto; Y Tokuda; Y Nakamura; A Suzuki; K Watanabe; M Yamamura; T Tajima; T Mitomi; K Nishijima
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Distinct reactivities of four monoclonal antibodies with human interleukin 2 receptor.

Authors:  Y Tanaka; H Tozawa; M Hayami; K Sugamura; Y Hinuma
Journal:  Microbiol Immunol       Date:  1985       Impact factor: 1.955

8.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

Authors:  T Takeshita; Y Goto; K Tada; K Nagata; H Asao; K Sugamura
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.

Authors:  S C Meuer; J C Hodgdon; R E Hussey; J P Protentis; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Activation of natural killer cells via the p75 interleukin 2 receptor.

Authors:  J H Phillips; T Takeshita; K Sugamura; L L Lanier
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  6 in total

1.  Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.

Authors:  A L Kinter; S M Bende; E C Hardy; R Jackson; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

2.  Flow cytometric characterisation of the "false naive" (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis.

Authors:  M Neidhart; F Pataki; J Schönbächler; P Brühlmann
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  Activated CD4+ T cells preferentially take up lipid microspheres, but resting cells do not.

Authors:  K Suzuki
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

Review 4.  Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement.

Authors:  A Kinter; A S Fauci
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

5.  Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.

Authors:  Y Nakamura; Y Tokuda; M Iwasawa; H Tsukamoto; M Kidokoro; N Kobayashi; S Kato; T Mitomi; S Habu; T Nishimura
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

6.  Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.

Authors:  T Nishimura; Y Nakamura; Y Takeuchi; X H Gao; Y Tokuda; K Okumura; S Habu
Journal:  Jpn J Cancer Res       Date:  1991-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.